Long-term success of percutaneously placed peritoneal dialysis catheters

, and diabetes accounted for 63% of kidney failure cases. Baseline characteristics were similar between groups except for lower BMI in the percutaneous cohort. Median catheter longevity was 20.3 months (IQR 6.8-36.0) for percutaneous placement and 17.0 months (IQR 7.2-30.8) for surgical placement. PD-related infections were the leading cause of catheter removal in both groups, while the rates of major and minor mechanical complications were comparable. To our knowledge, this is among the largest contemporary real-world cohorts evaluating long-term outcomes of percutaneous PD catheters, with follow-up extending beyond 5 years, and it addresses an important evidence gap. Percutaneous PD catheters demonstrated long-term survival and complication rates comparable to those of surgically placed catheters. These findings support broader adoption of percutaneous catheter placement to facilitate timely PD initiation and patient-centered modality selection.